Bastet 101

 

 

NASH initiation and progression is very complex.

 

Blocking multiple pathways will increase efficacy across a diverse population and disease pathogenisis.

Inhibits lipid synthesis by regulating the SREP1 pathway

 

Accelerates lipid oxidation/breakdown by binding PPAR-alpha which can modulate PPAR-gamma

 

Inhibits inflammation

 

 

Mitigates oxidative stress by having strong anti-oxidant activity

 

Print Print | Sitemap
© Bast Biotechnology - Powered by 1&1 IONOS